Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging

BACKGROUND: β-amyloid (Aβ) positron emission tomography (PET) imaging is currently the only Food and Drug Administration-approved method to support clinical diagnosis of Alzheimer’s disease (AD). However, numerous research studies support the use of cerebrospinal fluid (CSF) biomarkers, as a cost-ef...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Alzheimers Res Ther
Egile Nagusiak: Doecke, James D., Ward, Larry, Burnham, Samantha C., Villemagne, Victor L., Li, Qiao-Xin, Collins, Steven, Fowler, Christopher J., Manuilova, Ekaterina, Widmann, Monika, Rainey-Smith, Stephanie R., Martins, Ralph N., Masters, Colin L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7110644/
https://ncbi.nlm.nih.gov/pubmed/32234072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-020-00595-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak